CDSCO issues alert against 62 substandard drugs; Samples from Lupin, Jackson Laboratories flagged
时间:2024-06-02 03:46:33 阅读(143)
The Central Drugs Standard Control Organisation (CDSCO) has flagged 62 drug samples as they failed the quality test. The alert was issued by the drug regulator for November 2023.
The drug regulator’s list, as seen by Financial Express.com, reveals that 1197 drug samples were tested, out of which 1133 samples were of standard quality. 62 samples were not of standard quality, one sample was spurious and one sample was misbranded.
According to the drug regulator, dissolution, disintegration and assay are some of the reason of drug test failure. Lupin, Jackson Laboratories, E.G. Pharmaceuticals, Konis Pharmaceuticals, Biozenta Lifesciences Pvt., Aristo Pharmaceuticals, and Cotec Healthcare are some of the companies whose drug failed the quality test.
The regulator also issued a revised drug Alert for May 2022 which Omeprazole (Delayed-Release) and Domperidone (Sustained Release) Capsules, manufactured by Dr. Reddy’s Laboratories. CDSCO maintains that the assay of Omeprazole and Domperidone is the reason of failure.
“The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. Thus, the product is purported to be spurious, however, the same is subject to outcome of investigation,” it stated.
The drug combination belongs to a group of medicines called gastrointestinal agents used to treat heartburn, indigestion, epigastric pain, gastro-oesophageal reflux disease (GERD), peptic ulcers and Zollinger-Ellison syndrome.
猜你喜欢
- Wipro share price jumps 3% after board OKs Rs 12,000 crore buyback; Should you buy, hold, sell Wipro stock-
- Will Nifty top 19400 or fall in trade- See GIFT Nifty, FII data, F&O ban, crude, more before market opens
- Wipro Q4FY23 results this week- Net profit may grow in double digits; revenue to rise on strong deal wins
- Winning streak ends as consumer, auto stocks drag indices down
- Will Nifty trade above 21,700 levels or fall ahead- See GIFT Nifty, FII data, F&O ban, crude, more before market opens_1
- NSE Bulk deals, December 16- NDTV, GMM Pfaudler, PARACABLES and other major deals that took place on Friday
- Dip in dollar index augurs well for India flows
- Zephyr Peacock plans 7-9 investments from $100-million third fund in next 2 years
- With more local value additions, electronics manufacturing sector to be worth USD 115 billion in 2024